3320.HK 财务： China Resources Pharmaceutical Group Limited AI 分析

Q: 技术分析指标如何适用于 3320.HK？

根据技术分析，China Resources Pharmaceutical Group Limited 的综合信号为 Sell。China Resources Pharmaceutical Group Limited 有 2 个买入信号，2 个中性信号和 3 个卖出信号。

Q: 3320.HK 的斐波那契回调水平是多少？

China Resources Pharmaceutical Group Limited 的斐波那契回调水平是 在 0% 和 23.6% 之间。

Q: China Resources Pharmaceutical Group Limited 的 RSI 是多少？

China Resources Pharmaceutical Group Limited 的 RSI 目前为 34.62，表明处于 中立 状态

Q: China Resources Pharmaceutical Group Limited 接下来 12 个月的价格是多少？

China Resources Pharmaceutical Group Limited 3320.HK 接下来 12 个月的价格预计为 $6.8。

Q: China Resources Pharmaceutical Group Limited 预计会涨到多高？

据华尔街分析师称，China Resources Pharmaceutical Group Limited 预计将达到 $9.24 的高预测值。

主页

股票

3320.HK

预测

CHINARES PHARMA (3320.HK)

China Resources Pharmaceutical Group Limited

HK$4.54

盘中： Jan 20, 11:42:10 HKT

关键数据

前收盘价

$4.54

开盘价

$4.54

当日区间

$4.51 - $4.55

52周范围

$4.35 - $5.76

交易量

2.3M

平均成交量

12.6M

每股收益（TTM）

0.50

股息收益率

市值

$28.5B

什么是 CHINARES PHARMA？

China Resources Pharmaceutical Group Ltd. is an investment holding, which engages in the research and development, manufacture, distribution, and retail of pharmaceutical and healthcare products. The firm operates its business through four segments. The Pharmaceutical Business segment develops, manufactures and sells a range of pharmaceuticals and health products. The Pharmaceutical Distribution Business segment provides distribution, warehousing, logistics and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers, device manufacturer and dispensers, including hospitals, distributors and retail pharmacies. The Pharmaceutical Retail Business segment operates retail pharmacies. The Other Business Operations segment engages in property holding and other businesses.

功能特性

交易策略

资源

市场

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for 3320.HK in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $6.8. The lowest target is $5.65 and the highest is $9.24. Empower your investment choices with our cutting-edge, data-driven analysis!

3320.HK 股价预测摘要

3320.HK的顶级分析师评级

基于 17 位分析师对 3320.HK 的股票评级，更新于 Jan 01, 2026

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for 3320.HK. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: 3320.HK is a Buy candidate.

3320.HK stock price ended at $4.53 on 星期二, after dropping 0.22%

On the latest trading day Jan 20, 2026, the stock price of 3320.HK fell by 0.22%, dropping from $4.54 to $4.53. During the session, the stock saw a volatility of 0.89%, with prices oscillating between a daily low of $4.51 and a high of $4.55. On the latest trading day, the trading volume for 3320.HK decreased by 5.4M shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 2.0M shares were traded, with a market value of approximately $28.4B.

3320.HK 技术面信号

技术面信号摘要

购买信号 2

中性信号 2

卖出信号 3

Strong Sell

Sell

Neutral

Buy

Strong Buy

3320.HK目前显示2个买入信号和3个卖出信号。该股票自12:00 AM以来一直处于下降趋势状态，在此期间价格总变动为-0.22%。总体而言，技术指标显示中期前景为Sell。

3320.HK 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 3320.HK 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 3320.HK？



3320.HK 的斐波那契回调水平是多少？



China Resources Pharmaceutical Group Limited 的 RSI 是多少？



China Resources Pharmaceutical Group Limited 接下来 12 个月的价格是多少？



China Resources Pharmaceutical Group Limited 预计会涨到多高？



China Resources Pharmaceutical Group Limited（3320.HK）价格

3320.HK 股价走势图